Results 1 to 10 of about 13,199 (165)

Reducing inequities in access to postpartum hemorrhage prevention: Reframing advance distribution of misoprostol as a test case for health system responsiveness and adaptation [PDF]

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue S2, Page S26-S33, June 2026.
Abstract Advance distribution of misoprostol is an evidence‐based strategy for preventing postpartum hemorrhage (PPH) at births without skilled health personnel present. Despite its lifesaving potential, initial momentum behind this intervention has slowed over the last decade and has not been renewed since WHO released updated guidelines in 2020 or ...
Hannah Tappis   +4 more
wiley   +2 more sources

Igniting the spark in six countries to transform the trajectory of postpartum hemorrhage across the globe: An overview of the AMPLI‐PPHI project [PDF]

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue S2, Page S9-S16, June 2026.
Abstract Postpartum hemorrhage (PPH) remains the leading cause of maternal mortality worldwide, disproportionately affecting women in low‐ and middle‐income countries. Despite updated WHO recommendations and the availability of newer technologies—including heat‐stable carbetocin, tranexamic acid as part of a clinical care bundle, misoprostol, and ...
Elaine Roman
wiley   +2 more sources

The role of exchange hubs and learning between countries and regions in strengthening the implementation and expansion of essential products for postpartum hemorrhage [PDF]

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue S2, Page S51-S56, June 2026.
Abstract Postpartum hemorrhage (PPH) affects about 6%–10% of women giving birth and is the leading cause of maternal mortality worldwide. Following its launch in the Democratic Republic of the Congo, Guinea, India, and Kenya in October 2022, and more recently in Nigeria and Zambia, the Unitaid‐supported Accelerating Measurable Progress and Leveraging ...
Telly Sy   +8 more
wiley   +2 more sources

Moving beyond a legacy paradigm: A vision for equitable access to quality medicines in Africa [PDF]

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue S2, Page S44-S50, June 2026.
Abstract Ensuring the availability of quality medicines is fundamental to achieving health outcomes and safeguarding public health. However, in many low‐ and middle‐income countries, especially across Africa, the current quality assurance paradigm—largely driven by historical donor preferences for WHO prequalification and stringent regulatory authority
Naoko Doi   +9 more
wiley   +2 more sources

Role of professional associations in the drive for policy change and uptake of new WHO recommendations for the prevention and treatment of postpartum hemorrhage [PDF]

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue S2, Page S34-S43, June 2026.
Abstract The role of professional associations in the health ecosystem is crucial as they establish and uphold standards of professional practice, ethics, and continuing education, thereby safeguarding patient welfare and promoting accountability among practitioners.
Ruth Wamae   +4 more
wiley   +2 more sources

Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review. [PDF]

open access: yes, 2011
OBJECTIVE: To compare medical abortion practised at home and in clinics in terms of effectiveness, safety and acceptability. METHODS: A systematic search for randomized controlled trials and prospective cohort studies comparing home-based and clinic ...
Free, Caroline   +7 more
core   +1 more source

Misoprostol Induced Convulsion- A Rare Side Effect of Misoprostol

open access: yesJOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2017
Misoprostol, a synthetic prostaglandin E1 has wider application in obstetrics gynaecology. It has been recommended in the prophylaxis and treatment of Post Partum Haemorrhage (PPH) by Federation of Obstetrics and Gynaecology (FIGO), World Health Organisation (WHO) and American College of Obstetrics and Gynaecology (ACOG).
Nalini Sharma   +3 more
openaire   +3 more sources

Eventos adversos por el uso del misoprostol en embarazos a término en el Hospital Básico Divina Providencia de San Lorenzo

open access: yes, 2023
Tesis previa al grado magíster en Salud Pública mención Atención Integral en Urgencias y EmergenciasIntroducción: El uso del misoprostol al final del embarazo cumple una función importante para inducir el parto, estos procedimientos están relacionados ...
Sornoza Vega, Johanna Yasmin
core   +1 more source

Misoprostol vaginal insert versus misoprostol vaginal tablets for the induction of labour: a cohort study [PDF]

open access: yes, 2018
Background Misoprostol vaginal insert for induction of labor has been recently reported to be superior to dinoprostone vaginal insert in a phase III trial, but has never been compared to vaginal misoprostol in another galenic form.
Radan, Anda-Petronela   +13 more
core   +1 more source

Le misoprostol sur toutes les bouches: De l’autonomie en 12 comprimés [PDF]

open access: yes, 2021
Depuis les années 1980, dans des pays d’Amérique latine et des Caraïbes, notamment le Brésil, les femmes issues des secteurs populaires ont fait sur leur propre corps l’expérience de l’utilisation du misoprostol, dès sa mise en vente sur le marché ...
Szwarc, Lucila
core  

Home - About - Disclaimer - Privacy